Life Sciences

  • Microbiome / Nutrition / Foodtech / Lifestyle
  • Medtech / Connected health / Digital health
  • Biotech & pharmaceuticals
  • Industrial Biotech & Cleantech
  • Animal health / Animal Feed & Nutrition

Read more

Digital Technologies

  • Fintech
  • Retailtech
  • Other digital innovative solutions
  • Hardware & telecom

Read more

News

  • Intento Design secures the third round of investment to accelerate its commercial deployment
    24 June 2022

    Intento Design secures the third round of investment to accelerate its commercial deployment

    Intento Design, a Paris-based french company, developing...

    Read more...
  • Below you can find a link with presentation published by the magazine DECIDEURS about Blue Forward Fund™
    23 June 2022

    Below you can find a link with presentation published by the magazine DECIDEURS about Blue Forward Fund™

    Launched in December 2021 by Seventure Partners , Blue...

  • Galecto announces first patient enrolled in phase 2 trial of GB1211 in combination with Atezolizumab for first-line treatment of NSCLC
    23 June 2022

    Galecto announces first patient enrolled in phase 2 trial of GB1211 in combination with Atezolizumab for first-line treatment of NSCLC

    GB1211, Galecto's galectin-3 inhibitor, has shown potent...

    Read more...
  • Enterome presents proof-of-concept immune response data and first clinical data from Phase 1/2 trial with EO2401, a first-in-class OncoMimics™ therapeutic cancer vaccine for adrenocortical carcinoma, at ASCO 2022
    6 June 2022

    Enterome presents proof-of-concept immune response data and first clinical data from Phase 1/2 trial with EO2401, a first-in-class OncoMimics™ therapeutic cancer vaccine for adrenocortical carcinoma, at ASCO 2022

    Enterome, a clinical stage biopharmaceutical company...

  • Enterome presents proof-of-concept immune response data and first clinical data from Phase 1/2 trial with EO2401, a first-in-class OncoMimics™ therapeutic cancer vaccine for glioblastoma, at ASCO 2022
    6 June 2022

    Enterome presents proof-of-concept immune response data and first clinical data from Phase 1/2 trial with EO2401, a first-in-class OncoMimics™ therapeutic cancer vaccine for glioblastoma, at ASCO 2022

    Enterome, a clinical stage biopharmaceutical company...

Events

  • 30 January

    HUBDAY Future of Retail & E-Commerce

    Come & meet us !

  • 31 January

    Maddy Keynote

    Come & meet us !

  • 04 February

    France Digital Tour – Bordeaux

    Come & meet us !

  • 05 February

    FRANKFURT DIGITAL FINANCE

    Come & meet us !

  • 28 February

    Paris Fintech Forum

    Come & meet us !

Twitter

By continuing your browsing on this site, you accept the use of cookies to carry out statistics of anonymous visits. Read more

Authorize Refuse